T2D
DEAD

Serial Number

86530791

Owner

Intarcia Therapeutics, Inc.

Attorney

Maury M. Tepper, III

Filing Date

Feb 10, 2015

Add to watchlist:

No watchlists yet
View on USPTO

T2D Trademark

Serial Number: 86530791

T2D is a trademark filed by Intarcia Therapeutics, Inc. on February 10, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Intarcia Therapeutics, Inc. (49 trademarks)

One Marina Park Drive
Boston, MA 02210

Entity Type: 03

Trademark Details

Filing Date

February 10, 2015

Registration Date

Not Registered

Published for Opposition

January 5, 2016

Goods & Services

Development and dissemination of printed and electronic educational materials of others in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies and administration of pharmaceuticals; educational services, namely, conducting classes, seminars, conferences, workshops, field trips and programs in the fields of diabetes, obesity, metabolic diseases/disorders, and treatments relating thereto, drug delivery technologies and administration of pharmaceuticals, and distribution of educational material in connection therewith

Pharmaceutical preparations for the treatment of diabetes, obesity and metabolic diseases and disorders; drug delivery systems comprised of an implantable pump filled with pharmaceutical preparations for use in treating diabetes, obesity and metabolic diseases/disorders

Medical information services, namely, providing information on the topics of diabetes, obesity, and metabolic diseases/disorders and the diagnosis, treatment and management therapies relating thereto; providing information in the fields of medicine, pharmaceuticals, drug delivery technologies, and administration of pharmaceuticals

Drug delivery systems, namely an implantable pump; medical apparatus for the administration of pharmaceuticals in the nature of an implantable pump; medical apparatus for treatment of diabetes, obesity and metabolic diseases/disorders in the nature of an incretin memetic pump

Research and development of pharmaceutical preparations, products and technology in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals for others; medical and scientific research in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals; providing medical and scientific research information in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, administration of pharmaceuticals, pharmaceuticals, and clinical trials; scientific investigations for medical purposes; medical research; design and testing of new products, technologies and therapies in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals for others; providing information in the fields of clinical trials of pharmaceuticals

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Oct 9, 2018 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 8, 2018 ABN6
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 5, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 5, 2018 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 2, 2018 EXRA
SOU EXTENSION 4 GRANTED
Feb 28, 2018 EX4G
SOU EXTENSION 4 FILED
Feb 28, 2018 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 28, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 18, 2017 EXRA
SOU EXTENSION 3 GRANTED
Aug 16, 2017 EX3G
SOU EXTENSION 3 FILED
Aug 16, 2017 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 16, 2017 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 2, 2017 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 2, 2017 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 2, 2017 EXRA
SOU EXTENSION 2 GRANTED
Jan 31, 2017 EX2G
SOU EXTENSION 2 FILED
Jan 31, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 31, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 26, 2016 EXRA
SOU EXTENSION 1 GRANTED
Aug 24, 2016 EX1G
SOU EXTENSION 1 FILED
Aug 24, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 24, 2016 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 1, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 5, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jan 5, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 16, 2015 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 19, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 18, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 18, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 18, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 18, 2015 GNRN
NON-FINAL ACTION E-MAILED
May 18, 2015 GNRT
NON-FINAL ACTION WRITTEN
May 18, 2015 CNRT
ASSIGNED TO EXAMINER
May 15, 2015 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 26, 2015 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 25, 2015 NWOS
NEW APPLICATION ENTERED
Feb 13, 2015 NWAP